An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

NCT01339260 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1455

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy-Induced Nausea and Vomiting

Interventions

DRUG: Netupitant and Palonosetron
DRUG: Palonosetron
DRUG: Dexamethasone

Sponsor

Helsinn Healthcare SA

Collaborators

[object Object]